The personal pain goal is inadequate for assessing outcomes of cancer pain management; goals should include function, medication effects, and safety. Cancer patients need a more comprehensive means of ...

mCRC treatment involves balancing efficacy, tolerability, and patient goals, with fruquintinib, regorafenib, and trifluridine-tipiracil as key therapies. Oncology pharmacists are essential in ...

Although survival rates are high, thyroid cancer patients often face unnecessary treatments due to the reliance on inaccurate ...

Please provide your email address to receive an email when new articles are posted on . Shared decision-making and survivorship were two areas of emphasis in the ATA’s 2025 thyroid cancer guideline.

Predictive genomics enhances breast cancer management by integrating predictive medicine, personal genomics, and translational bioinformatics for personalized care. Key applications include ...

Cancer continues to be employers' biggest treatment cost, driving up healthcare spending. Costs for cancer-related medical services and drugs are expected to reach nearly $250 billion in the U.S. by ...

ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...

The Bermuda Cancer and Health Centre is marking “more than two decades of sustained commitment to cancer genetics and ...